Correlation Between Opthea and Aligos Therapeutics
Can any of the company-specific risk be diversified away by investing in both Opthea and Aligos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opthea and Aligos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Opthea and Aligos Therapeutics, you can compare the effects of market volatilities on Opthea and Aligos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opthea with a short position of Aligos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opthea and Aligos Therapeutics.
Diversification Opportunities for Opthea and Aligos Therapeutics
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Opthea and Aligos is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Opthea and Aligos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aligos Therapeutics and Opthea is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opthea are associated (or correlated) with Aligos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aligos Therapeutics has no effect on the direction of Opthea i.e., Opthea and Aligos Therapeutics go up and down completely randomly.
Pair Corralation between Opthea and Aligos Therapeutics
Considering the 90-day investment horizon Opthea is expected to under-perform the Aligos Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Opthea is 2.38 times less risky than Aligos Therapeutics. The stock trades about -0.16 of its potential returns per unit of risk. The Aligos Therapeutics is currently generating about 0.51 of returns per unit of risk over similar time horizon. If you would invest 955.00 in Aligos Therapeutics on September 2, 2024 and sell it today you would earn a total of 1,596 from holding Aligos Therapeutics or generate 167.12% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Opthea vs. Aligos Therapeutics
Performance |
| Timeline |
| Opthea |
| Aligos Therapeutics |
Opthea and Aligos Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Opthea and Aligos Therapeutics
The main advantage of trading using opposite Opthea and Aligos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opthea position performs unexpectedly, Aligos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aligos Therapeutics will offset losses from the drop in Aligos Therapeutics' long position.| Opthea vs. Molecular Partners AG | Opthea vs. MediciNova | Opthea vs. Anebulo Pharmaceuticals | Opthea vs. Champions Oncology |
| Aligos Therapeutics vs. Tff Pharmaceuticals | Aligos Therapeutics vs. Eliem Therapeutics | Aligos Therapeutics vs. Inhibrx | Aligos Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |